NutriDex

The Supplement Research Compendium
🍼

Human Milk Oligosaccharides (2'-FL)

2'-fucosyllactose

The most abundant human milk oligosaccharide — a selectively bifidogenic prebiotic now made by microbial fermentation for infant formula and adult gut-health supplements.

Moderate evidence 🌾Prebiotics & Fibers🛡️Gut & Immune

✚ Updated · How we grade evidence

Evidence tier
Moderate
Research weight
Citations
10 verified / 10
Classification
Prebiotics & Fibers
❝
What the evidence says. Several controlled trials; effects real but modest or context-dependent.

What is Human Milk Oligosaccharides (2'-FL)?

Human Milk Oligosaccharides (2'-FL) (2'-fucosyllactose) is a prebiotic fiber used for selectively bifidogenic: randomized trials in infants and adults reproducibly increase relative abundance of bifidobacterium (and actinobacteria) while reducing proteobacteria/firmicutes, the most consistent and best-evidenced effect. NutriDex grades the human evidence as Moderate. 2'-Fucosyllactose (2'-FL) is the most abundant oligosaccharide in the breast milk of "secretor" mothers, now produced commercially by microbial fermentation and added to infant formula and adult prebiotic supplements. It resists human digestion and is selectively fermented by Bifidobacterium, and randomized trials in infants, healthy adults, and older adults consistently show a robust bifidogenic shift in the gut microbiota with good tolerability up to ~20 g/day. The clinical evidence is strongest for the microbiome effect itself and for tolerability/safety; downstream benefits (IBS symptom relief, metabolic and cognitive markers, infant infection reduction) are more preliminary, with several trials missing their primary clinical endpoints or showing benefit only in pre-specified subgroups. It is not the same class of evidence as oat beta-glucan or psyllium, which carry FDA heart-health claims — 2'-FL has no authorized health claim, but it has GRAS status and EFSA novel-food approval.

Purported Benefits

✓Selectively bifidogenic: randomized trials in infants and adults reproducibly increase relative abundance of Bifidobacterium (and Actinobacteria) while reducing Proteobacteria/Firmicutes, the most consistent and best-evidenced effect
✓Well tolerated as a prebiotic up to ~20 g/day with only dose-dependent flatulence/bloating, unlike many highly fermentable FODMAP fibers
✓May improve irritable bowel syndrome symptoms (stool consistency, abdominal pain, bloating, quality of life) — supported by an open-label multicenter trial, though a blinded RCT found no symptom advantage over placebo
✓In older adults, a 2025 RCT linked 2'-FL to higher serum HDL cholesterol, insulin and FGF21, with cognitive/visual-memory benefit in Bifidobacterium 'responders' (exploratory, primary cytokine endpoint not met)
✓In infant formula, supports age-appropriate growth and is associated in some trials with fewer lower-respiratory and bronchitis events and reduced antibiotic/antipyretic use (findings inconsistent across studies)
✓Acts as a decoy receptor and may modulate gut-barrier and immune function, mechanisms supported by preclinical and infant data

Evidence by outcome

The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.

OutcomeEvidenceEffectStudies
Selectively increases Bifidobacterium (bifidogenic)Reproducible across adult and infant RCTs; the most consistent and best-evidenced effect. Moderate ↑ benefit · large 3
Well tolerated up to ~20 g/dayRCTs show only dose-dependent flatulence/bloating; favorable vs many FODMAP fibers. Moderate ↑ benefit · moderate 2
Improves IBS symptomsOpen-label trial positive but uncontrolled; blinded RCT found no symptom advantage over placebo. Mixed ↔ mixed · small 2
Improves metabolic/cognitive markers in older adults2025 RCT: raised HDL/insulin/FGF21 but missed primary cytokine endpoint; cognition only in responders. Exploratory. Preliminary ↔ mixed · small 1
Reduces infant infections / supports growthSupports age-appropriate growth; infection/medication-use signals inconsistent and often non-significant across trials. Mixed ↔ mixed · small 3

Dosing & Compounds

Typical Dose
Adult gut-health trials use ~1-20 g/day, most commonly 5 g/day of 2'-FL (or a 4:1 2'-FL:LNnT mix); tolerability studies tested up to 20 g/day for 2 weeks. Older-adult RCT used 1 g/day (low) or 5 g/day (high). Taken as a powder dissolved in water or food, once daily; infant formula provides roughly 0.2-1.0 g/L. Start low and titrate up to limit gas.
Active Compounds
Standalone adult supplements: Layer Origin PureHMO 2'-FL powder, kepos, Holigos/Layer Origin capsulesInfant formula with added 2'-FL: Similac (Abbott), Enfamil/Nestlé NAN/Gerber Good Start, Aptamil and store-brand formulasBulk fermentation-derived ingredient brands: Friesland Campina (Aequival), DSM-Firmenich (GlyCare 2FL), Chr. Hansen, InbioseOften combined with LNnT (lacto-N-neotetraose) in a 4:1 or 2:1 mix in clinical trialsNaturally present in human breast milk of secretor (FUT2-positive) mothers; not found in standard cow's-milk dairy

Safety & Cautions

Generally well tolerated; the main side effects are dose-dependent flatulence, bloating, abdominal discomfort and altered stool, mostly at the highest doses (10-20 g/day) and usually transient. As a fermentable oligosaccharide it is a FODMAP-type substrate, so people with sensitive guts or active IBS should start low (e.g. ~1-2 g/day) and titrate slowly. It has FDA GRAS status and EFSA novel-food authorization and is added to infant formula at regulated levels. Because 2'-FL is largely lactose-based, products are typically suitable for lactose-intolerant adults (the oligosaccharide is not digested), but galactosemia and rare carbohydrate-metabolism disorders warrant caution. No major drug interactions are established, but as with other viscous/fermentable fibers it is prudent to separate from time-critical oral medications. Long-term safety data in adults beyond a few weeks to months are limited; pregnant/breastfeeding individuals and those with serious GI disease should consult a clinician. Educational only — always check with your doctor or pharmacist before combining Human Milk Oligosaccharides (2'-FL) with any medicine.

Key Studies ★ 10 studies

Randomized controlled trial Schmidt 2025 (Cell Reports Medicine) ✓ Source
6-week RCT in 89 healthy older adults (mean 67y): 2'-FL (1 or 5 g/day) raised gut Bifidobacterium, serum insulin, HDL cholesterol and FGF21; the primary cytokine endpoint was not met, and cognitive/visual-memory gains appeared only in Bifidobacterium 'responders'.
Randomized controlled trial Bifidogenic infant RCT 2025 (Nutrients) ✓ Full text
RCT in healthy formula-fed infants: formula with 2'-FL produced higher Bifidobacterium relative abundance (59.5%) than GOS+FOS formula (24.4%), demonstrating a strong species-level bifidogenic effect.
Randomized controlled trial Iribarren 2020 (Neurogastroenterol Motil) ✓ Full text
Parallel, double-blind, placebo-controlled RCT in IBS patients: 4:1 2'-FL/LNnT at 5 or 10 g/day for 4 weeks increased fecal Bifidobacterium (10 g group) and was well tolerated, but overall and individual GI symptoms did not differ from placebo.
Open-label trial Palsson 2020 (Clin Transl Gastroenterol) ✓ Full text
Multicenter open-label trial in 317 IBS patients: 5 g/day 2'-FL+LNnT (4:1) for 12 weeks normalized stool consistency and significantly reduced abdominal pain and bloating with improved quality of life across all IBS subtypes (no placebo arm).
Randomized controlled trial Nestlé probiotic + 2'-FL RCT 2022 (Nutr J) ✓ Full text
Double-blind RCT: probiotic infant formula supplemented with 2'-FL was safe and supported normal growth; medication use was similar between groups (~83.9% vs 81.1%), with respiratory-infection differences not reaching significance.
RCT Parschat 2022 ✓ Source
Double-blind RCT of a probiotic-containing infant formula supplemented with 2'-fucosyllactose found the formula safe, well-tolerated, and supporting age-appropriate growth versus control.
RCT Elison 2021 ✓ Full text
Pilot clinical trial in adults with IBS or ulcerative colitis found a 2'-FL-containing formula increased GIQLI symptom scores, stool Bifidobacterium and Faecalibacterium prausnitzii, and butyrate after 6 weeks.
Randomized controlled trial Elison 2016 (Br J Nutr) ✓ Full text
RCT in 100 healthy adults: 2'-FL and LNnT at up to 20 g/day for 2 weeks were safe and well tolerated and selectively increased relative abundance of Actinobacteria and Bifidobacterium while reducing Firmicutes and Proteobacteria.
Randomized controlled trial Storm 2019 (Glob Pediatr Health) ✓ Full text
RCT in term infants: a 100% whey, partially hydrolyzed formula with B. lactis and 2'-FL was well tolerated and supported age-appropriate growth with no safety concerns versus control formula.
Observational PGHN 2025 ✓ Full text
In a 1-year comparison of breastfed, formula-fed, and 2'-FL-supplemented formula-fed term infants, 2'-FL supplementation was associated with reduced risk of infantile colic and atopic dermatitis in infancy.
10 sources cited · 10 verified Search all studies on PubMed ↗

Common questions about Human Milk Oligosaccharides (2'-FL)

What is Human Milk Oligosaccharides (2'-FL) used for?

Human Milk Oligosaccharides (2'-FL) is most often taken for Selectively bifidogenic: randomized trials in infants and adults reproducibly increase relative abundance of Bifidobacterium (and Actinobacteria) while reducing Proteobacteria/Firmicutes, the most consistent and best-evidenced effect, Well tolerated as a prebiotic up to ~20 g/day with only dose-dependent flatulence/bloating, unlike many highly fermentable FODMAP fibers, May improve irritable bowel syndrome symptoms (stool consistency, abdominal pain, bloating, quality of life) — supported by an open-label multicenter trial, though a blinded RCT found no symptom advantage over placebo, In older adults, a 2025 RCT linked 2'-FL to higher serum HDL cholesterol, insulin and FGF21, with cognitive/visual-memory benefit in Bifidobacterium 'responders' (exploratory, primary cytokine endpoint not met). The most abundant human milk oligosaccharide — a selectively bifidogenic prebiotic now made by microbial fermentation for infant formula and adult gut-health supplements.

Does Human Milk Oligosaccharides (2'-FL) work — what does the evidence say?

Moderate evidence. Several controlled trials; effects real but modest or context-dependent. 2'-Fucosyllactose (2'-FL) is the most abundant oligosaccharide in the breast milk of "secretor" mothers, now produced commercially by microbial fermentation and added to infant formula and adult prebiotic supplements. It resists human digestion and is selectively fermented by Bifidobacterium, and randomized trials in infants, healthy adults, and older adults consistently show a robust bifidogenic shift in the gut microbiota with good tolerability up to ~20 g/day. The clinical evidence is strongest for the microbiome effect itself and for tolerability/safety; downstream benefits (IBS symptom relief, metabolic and cognitive markers, infant infection reduction) are more preliminary, with several trials missing their primary clinical endpoints or showing benefit only in pre-specified subgroups. It is not the same class of evidence as oat beta-glucan or psyllium, which carry FDA heart-health claims — 2'-FL has no authorized health claim, but it has GRAS status and EFSA novel-food approval.

What is the typical dose of Human Milk Oligosaccharides (2'-FL)?

Adult gut-health trials use ~1-20 g/day, most commonly 5 g/day of 2'-FL (or a 4:1 2'-FL:LNnT mix); tolerability studies tested up to 20 g/day for 2 weeks. Older-adult RCT used 1 g/day (low) or 5 g/day (high). Taken as a powder dissolved in water or food, once daily; infant formula provides roughly 0.2-1.0 g/L. Start low and titrate up to limit gas.

Is Human Milk Oligosaccharides (2'-FL) safe? Any cautions or side effects?

Generally well tolerated; the main side effects are dose-dependent flatulence, bloating, abdominal discomfort and altered stool, mostly at the highest doses (10-20 g/day) and usually transient. As a fermentable oligosaccharide it is a FODMAP-type substrate, so people with sensitive guts or active IBS should start low (e.g. ~1-2 g/day) and titrate slowly. It has FDA GRAS status and EFSA novel-food authorization and is added to infant formula at regulated levels. Because 2'-FL is largely lactose-based, products are typically suitable for lactose-intolerant adults (the oligosaccharide is not digested), but galactosemia and rare carbohydrate-metabolism disorders warrant caution. No major drug interactions are established, but as with other viscous/fermentable fibers it is prudent to separate from time-critical oral medications. Long-term safety data in adults beyond a few weeks to months are limited; pregnant/breastfeeding individuals and those with serious GI disease should consult a clinician.

How many studies support Human Milk Oligosaccharides (2'-FL)?

NutriDex cites 10 sources for Human Milk Oligosaccharides (2'-FL), graded "Moderate".

Cite this page
APA

Peh, D. (2026). Human Milk Oligosaccharides (2'-FL) (2'-fucosyllactose): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 26 Jun 2026, from https://nutridex.info/s/hmo-2fl

BibTeX
@misc{nutridex_hmo_2fl,
  author       = {Peh, Daryl},
  title        = {Human Milk Oligosaccharides (2'-FL) (2'-fucosyllactose): Benefits, Dosage, Side Effects \& Evidence},
  year         = {2026},
  howpublished = {NutriDex --- The Supplement Research Compendium},
  url          = {https://nutridex.info/s/hmo-2fl},
  note         = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-06-26}
}

For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.

← Back to the full dex · All substances